Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Placebo-controlled Clinical Trial of Monthly DHA-piperaquine for Malaria Prevention in Cambodia.

NCT01624337 is registered in ClinicalTrials.gov with Armed Forces Research Institute of Medical Sciences, Thailand as lead sponsor.

NCT NCT01624337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01624337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Placebo-controlled Clinical Trial of Monthly DHA-piperaquine for Malaria Prevention in Cambodia.
Lead sponsor
Armed Forces Research Institute of Medical Sciences, Thailand
Phase
Not applicable
Overall status
Terminated
Start date
May 31, 2012
Completion date
June 30, 2015
Enrollment
231 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria